# City of Hope Medical Center: Phase 1 study closed enrollment, 56 enrolled (Acute Myeloid Leukemia)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | City of Hope Medical Center |
| Sponsor type | Academic and hospital |
| Study | Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia |
| NCT ID | NCT03467386 |
| Phase | Phase 1 |
| Status | active not recruiting |
| Conditions | Acute Myeloid Leukemia |
| Intervention types | procedure, drug, biological, other, radiation |
| Target enrollment | 56 |
| Site countries | United States |
| Posted | 2018-03-16 |
| Planned start | 2018-03-19 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-05 |
| Last update posted | 2026-10-05 |

## Why this score
- Enrollment closed: data management, monitoring and closeout ahead.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT03467386). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.